Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

GHN Pharma AB

Closing information (x1000 NOK)

Closing information 2024/12 (consolidated) 2023/12 2022/12
Turnover 167,037 Less Arrow 2,023 Less Arrow 280
Financial expenses 179 Less Arrow 11 More Arrow 2,304
Earnings before taxes 30,052 Less Arrow 5,359 Less Arrow -2,814
EBITDA 20,844 Less Arrow -61 Less Arrow -1,905
Total assets 176,946 Less Arrow 96,790 Less Arrow 85,718
Current assets 72,884 Less Arrow 3,008 Less Arrow 2,273
Current liabilities 32,225 Less Arrow 857 Less Arrow 199
Equity capital 134,957 Less Arrow 95,933 Less Arrow 85,519
- share capital 425 Less Arrow 417 Less Arrow 390
Employees (average) 7 Less Arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Solvency 76.3% More Arrow 99.1% More Arrow 99.8%
Turnover per employee 23,862 Less Arrow 1,012 Less Arrow 140
Profit as a percentage of turnover 18.0% More Arrow 264.9% Less Arrow -1005.0%
Return on assets (ROA) 17.1% Less Arrow 5.5% Less Arrow -0.6%
Current ratio 226.2% More Arrow 351.0% More Arrow 1142.2%
Return on equity (ROE) 22.3% Less Arrow 5.6% Less Arrow -3.3%
Change turnover
Change turnover % 575% Less Arrow -95%
Chg. No. of employees
Chg. No. of employees % 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.